Review





Similar Products

94
Bioss anti serpinf1
Anti Serpinf1, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti serpinf1/product/Bioss
Average 94 stars, based on 1 article reviews
anti serpinf1 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

94
Proteintech serpinf1
Serpinf1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/serpinf1/product/Proteintech
Average 94 stars, based on 1 article reviews
serpinf1 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc goat anti rabbit antibodies for pedf
Goat Anti Rabbit Antibodies For Pedf, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat anti rabbit antibodies for pedf/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
goat anti rabbit antibodies for pedf - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology pedf
Pedf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pedf/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
pedf - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

90
MedGen Inc mouse monoclonal anti-pedf n antibody sd-2
Mouse Monoclonal Anti Pedf N Antibody Sd 2, supplied by MedGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti-pedf n antibody sd-2/product/MedGen Inc
Average 90 stars, based on 1 article reviews
mouse monoclonal anti-pedf n antibody sd-2 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
MedGen Inc anti-pedf n antibody
Anti Pedf N Antibody, supplied by MedGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-pedf n antibody/product/MedGen Inc
Average 90 stars, based on 1 article reviews
anti-pedf n antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Millipore anti-pigment epithelium–derived factor (anti-pedf)
Anti Pigment Epithelium–Derived Factor (Anti Pedf), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-pigment epithelium–derived factor (anti-pedf)/product/Millipore
Average 90 stars, based on 1 article reviews
anti-pigment epithelium–derived factor (anti-pedf) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Medgene Labs anti-pedf np sd-2-1
Anti Pedf Np Sd 2 1, supplied by Medgene Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-pedf np sd-2-1/product/Medgene Labs
Average 90 stars, based on 1 article reviews
anti-pedf np sd-2-1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
MyBiosource Biotechnology anti-pedf antibody mbs560870
Sequences of crRNAs designed to target <t> PEDV </t>
Anti Pedf Antibody Mbs560870, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-pedf antibody mbs560870/product/MyBiosource Biotechnology
Average 90 stars, based on 1 article reviews
anti-pedf antibody mbs560870 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Sequences of crRNAs designed to target  PEDV

Journal: The Journal of General Virology

Article Title: Targeting pseudoknots with Cas13b inhibits porcine epidemic diarrhoea virus replication

doi: 10.1099/jgv.0.002071

Figure Lengend Snippet: Sequences of crRNAs designed to target PEDV

Article Snippet: Subsequently, it was incubated with anti-PEDV antibody (MBS560870; MyBiosource) and GAPDH antibody (sc-47724; Santa Cruz Biotechnology) for 2 h at room temperature on a shaker.

Techniques:

Comparison of PEDV variant pseudoknot sequences and crRNA production. ( a ) Alignment of slippery and pseudoknot sequences between SARS-CoV-2 and PEDV. The alignment compares nucleotide sequences, highlighting the slippery site (boxed) and pseudoknot site (grey) between SARS-CoV-2 and PEDV. Identical nucleotides are marked with asterisks (*) and differences with periods (.) below the sequences. Gaps are shown as dashes (-). ( b ) Sequence diversity among PEDV variants, including CV777, OH851 and CKK1-1. The top diagram shows the general genome organization of PEDV. The bottom diagram shows the multiple sequence alignment generated via CLUSTALW that compares the slippery region (boxed) and pseudoknot region (grey) among three PEDV variants. ( c ) CRISPR-Cas13b system targeting the RdRp ) gene of PEDV. The diagram illustrates CRISPR-Cas13b targeting the RdRp gene, indicating the pseudoknot and nonpseudoknot crRNA sites. ( d ) Schematic of the secondary structures of the PEDV slippery and pseudoknot regions with crRNA targeting sites marked. Sequences targeted by crRNAs #1, #2 and #3 are indicated by the red, green and blue bands, respectively.

Journal: The Journal of General Virology

Article Title: Targeting pseudoknots with Cas13b inhibits porcine epidemic diarrhoea virus replication

doi: 10.1099/jgv.0.002071

Figure Lengend Snippet: Comparison of PEDV variant pseudoknot sequences and crRNA production. ( a ) Alignment of slippery and pseudoknot sequences between SARS-CoV-2 and PEDV. The alignment compares nucleotide sequences, highlighting the slippery site (boxed) and pseudoknot site (grey) between SARS-CoV-2 and PEDV. Identical nucleotides are marked with asterisks (*) and differences with periods (.) below the sequences. Gaps are shown as dashes (-). ( b ) Sequence diversity among PEDV variants, including CV777, OH851 and CKK1-1. The top diagram shows the general genome organization of PEDV. The bottom diagram shows the multiple sequence alignment generated via CLUSTALW that compares the slippery region (boxed) and pseudoknot region (grey) among three PEDV variants. ( c ) CRISPR-Cas13b system targeting the RdRp ) gene of PEDV. The diagram illustrates CRISPR-Cas13b targeting the RdRp gene, indicating the pseudoknot and nonpseudoknot crRNA sites. ( d ) Schematic of the secondary structures of the PEDV slippery and pseudoknot regions with crRNA targeting sites marked. Sequences targeted by crRNAs #1, #2 and #3 are indicated by the red, green and blue bands, respectively.

Article Snippet: Subsequently, it was incubated with anti-PEDV antibody (MBS560870; MyBiosource) and GAPDH antibody (sc-47724; Santa Cruz Biotechnology) for 2 h at room temperature on a shaker.

Techniques: Comparison, Variant Assay, Sequencing, Generated, CRISPR

Potent inhibition of PEDV transmission via pseudoknot-targeting crRNA #3. ( a ) Quantification of PEDV gene expression. Vero cells were transfected with Cas13b mRNA and crRNAs targeting CKK1-1 of the PEDV strain 24 h before infection. After 24 h, RNA was extracted, and PEDV RdRp and membrane gene expression levels were quantified using qRT-PCR. Results were normalized to RNA expression in cells transfected with nontargeting crRNAs. ( b ) Representative images of PEDV protein (green) and DAPI (blue) staining in Vero cells. Viral protein levels from ( a ) were visualized under a fluorescence microscope. Scale bar: 50 µm. ( c ) Quantification of the percentage of PEDV protein-positive cells relative to DAPI-positive cells, tested as in ( b ). Green bars represent PEDV protein-positive cells compared with total cells (DAPI-positive cells). ( d ) Total proteins from the infected cells in ( a ) were analysed using a western blot assay. Intensity ratios of PEDV proteins, normalized to GAPDH, are shown above and below each corresponding protein band. ( e ) Quantification of PEDV titre. Vero cells were infected with the virus from ( a ). Titration was performed using a plaque assay at 4 dpi. The dilution factor multiplied by the plaque count was used to determine the virus titre ( n =3 for each group). Values are means± sem . One-way ANOVA was used for statistical analysis. *** P <0.0001.

Journal: The Journal of General Virology

Article Title: Targeting pseudoknots with Cas13b inhibits porcine epidemic diarrhoea virus replication

doi: 10.1099/jgv.0.002071

Figure Lengend Snippet: Potent inhibition of PEDV transmission via pseudoknot-targeting crRNA #3. ( a ) Quantification of PEDV gene expression. Vero cells were transfected with Cas13b mRNA and crRNAs targeting CKK1-1 of the PEDV strain 24 h before infection. After 24 h, RNA was extracted, and PEDV RdRp and membrane gene expression levels were quantified using qRT-PCR. Results were normalized to RNA expression in cells transfected with nontargeting crRNAs. ( b ) Representative images of PEDV protein (green) and DAPI (blue) staining in Vero cells. Viral protein levels from ( a ) were visualized under a fluorescence microscope. Scale bar: 50 µm. ( c ) Quantification of the percentage of PEDV protein-positive cells relative to DAPI-positive cells, tested as in ( b ). Green bars represent PEDV protein-positive cells compared with total cells (DAPI-positive cells). ( d ) Total proteins from the infected cells in ( a ) were analysed using a western blot assay. Intensity ratios of PEDV proteins, normalized to GAPDH, are shown above and below each corresponding protein band. ( e ) Quantification of PEDV titre. Vero cells were infected with the virus from ( a ). Titration was performed using a plaque assay at 4 dpi. The dilution factor multiplied by the plaque count was used to determine the virus titre ( n =3 for each group). Values are means± sem . One-way ANOVA was used for statistical analysis. *** P <0.0001.

Article Snippet: Subsequently, it was incubated with anti-PEDV antibody (MBS560870; MyBiosource) and GAPDH antibody (sc-47724; Santa Cruz Biotechnology) for 2 h at room temperature on a shaker.

Techniques: Inhibition, Transmission Assay, Gene Expression, Transfection, Infection, Membrane, Quantitative RT-PCR, RNA Expression, Staining, Fluorescence, Microscopy, Western Blot, Virus, Titration, Plaque Assay

Optimization of Cas13b and crRNA for enhanced antiviral activity against PEDV in a dose-dependent manner. (a) Quantification of PEDV gene copies. Vero cells were transfected with 0.5 µg of either crRNA #3 or nontarget crRNA and varying amounts of Cas13b mRNA (0.5, 1.0, 1.5 or 2.0 µg). At 24 h post-transfection, cells were infected with PEDV (0.05 m.o.i.). After another 24 h, PEDV RdRp and membrane gene expression levels in total RNA were quantified using qRT-PCR. Results were normalized to RNA expression in cells transfected with nontargeting crRNAs. (b) The same RNA transfection from (a) was followed by a luminescent cell viability assay (ATP assay) 48 h later. Bioluminescence values were normalized to those of untreated cells. (c) Vero cells were transfected with 2 µg of Cas13b mRNA and various amounts of crRNA #3 (0.1, 0.2, 0.5 or 1.0 µg). After 24 h, the cells were infected with PEDV, and 24 h later, PEDV RdRp and membrane gene expression levels were quantified using qRT-PCR. Results were normalized to RNA expression in cells transfected with nontargeting crRNAs. (d) Luminescent cell viability assay (ATP assay) was performed 48 h after transfection, as shown in (c). Bioluminescence values were normalized to those of untreated cells. Values are means± sem . One-way ANOVA was used for statistical analysis. *** P <0.0001.

Journal: The Journal of General Virology

Article Title: Targeting pseudoknots with Cas13b inhibits porcine epidemic diarrhoea virus replication

doi: 10.1099/jgv.0.002071

Figure Lengend Snippet: Optimization of Cas13b and crRNA for enhanced antiviral activity against PEDV in a dose-dependent manner. (a) Quantification of PEDV gene copies. Vero cells were transfected with 0.5 µg of either crRNA #3 or nontarget crRNA and varying amounts of Cas13b mRNA (0.5, 1.0, 1.5 or 2.0 µg). At 24 h post-transfection, cells were infected with PEDV (0.05 m.o.i.). After another 24 h, PEDV RdRp and membrane gene expression levels in total RNA were quantified using qRT-PCR. Results were normalized to RNA expression in cells transfected with nontargeting crRNAs. (b) The same RNA transfection from (a) was followed by a luminescent cell viability assay (ATP assay) 48 h later. Bioluminescence values were normalized to those of untreated cells. (c) Vero cells were transfected with 2 µg of Cas13b mRNA and various amounts of crRNA #3 (0.1, 0.2, 0.5 or 1.0 µg). After 24 h, the cells were infected with PEDV, and 24 h later, PEDV RdRp and membrane gene expression levels were quantified using qRT-PCR. Results were normalized to RNA expression in cells transfected with nontargeting crRNAs. (d) Luminescent cell viability assay (ATP assay) was performed 48 h after transfection, as shown in (c). Bioluminescence values were normalized to those of untreated cells. Values are means± sem . One-way ANOVA was used for statistical analysis. *** P <0.0001.

Article Snippet: Subsequently, it was incubated with anti-PEDV antibody (MBS560870; MyBiosource) and GAPDH antibody (sc-47724; Santa Cruz Biotechnology) for 2 h at room temperature on a shaker.

Techniques: Activity Assay, Transfection, Infection, Membrane, Gene Expression, Quantitative RT-PCR, RNA Expression, Cell Viability Assay, ATP Assay

Inhibition of PEDV transmission via merafloxacin, a pseudoknot formation inhibitor. ( a ) Quantification of PEDV gene copies. Vero cells were infected with PEDV and treated with the indicated merafloxacin concentrations 1 h later. After 24 h, PEDV RdRp gene expression was quantified using qRT-PCR. Results were normalized to RNA expression in cells treated with DMSO. ( b ) Representative immunofluorescence images of PEDV protein (green) and DAPI (blue) staining in Vero cells. Images are from one of three replicates. Scale bars: 50 µm. ( c ) Quantification of the percentage of PEDV protein-positive cells relative to DAPI-positive cells, tested as in ( b ). ( d ) Cytotoxicity quantification following merafloxacin treatment. Vero cells were treated with the indicated concentrations of merafloxacin dissolved in DMSO. After 24 h, a luminescent cell viability assay (ATP assay) was performed. Bioluminescence values were normalized to those of untreated cells. Values are means± sem .

Journal: The Journal of General Virology

Article Title: Targeting pseudoknots with Cas13b inhibits porcine epidemic diarrhoea virus replication

doi: 10.1099/jgv.0.002071

Figure Lengend Snippet: Inhibition of PEDV transmission via merafloxacin, a pseudoknot formation inhibitor. ( a ) Quantification of PEDV gene copies. Vero cells were infected with PEDV and treated with the indicated merafloxacin concentrations 1 h later. After 24 h, PEDV RdRp gene expression was quantified using qRT-PCR. Results were normalized to RNA expression in cells treated with DMSO. ( b ) Representative immunofluorescence images of PEDV protein (green) and DAPI (blue) staining in Vero cells. Images are from one of three replicates. Scale bars: 50 µm. ( c ) Quantification of the percentage of PEDV protein-positive cells relative to DAPI-positive cells, tested as in ( b ). ( d ) Cytotoxicity quantification following merafloxacin treatment. Vero cells were treated with the indicated concentrations of merafloxacin dissolved in DMSO. After 24 h, a luminescent cell viability assay (ATP assay) was performed. Bioluminescence values were normalized to those of untreated cells. Values are means± sem .

Article Snippet: Subsequently, it was incubated with anti-PEDV antibody (MBS560870; MyBiosource) and GAPDH antibody (sc-47724; Santa Cruz Biotechnology) for 2 h at room temperature on a shaker.

Techniques: Inhibition, Transmission Assay, Infection, Gene Expression, Quantitative RT-PCR, RNA Expression, Immunofluorescence, Staining, Cell Viability Assay, ATP Assay